472 related articles for article (PubMed ID: 10993727)
1. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha.
Bogan AA; Dallas-Yang Q; Ruse MD; Maeda Y; Jiang G; Nepomuceno L; Scanlan TS; Cohen FE; Sladek FM
J Mol Biol; 2000 Sep; 302(4):831-51. PubMed ID: 10993727
[TBL] [Abstract][Full Text] [Related]
2. Critical role of charged residues in helix 7 of the ligand binding domain in Hepatocyte Nuclear Factor 4alpha dimerisation and transcriptional activity.
Eeckhoute J; Oxombre B; Formstecher P; Lefebvre P; Laine B
Nucleic Acids Res; 2003 Nov; 31(22):6640-50. PubMed ID: 14602925
[TBL] [Abstract][Full Text] [Related]
3. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization.
Sladek FM; Dallas-Yang Q; Nepomuceno L
Diabetes; 1998 Jun; 47(6):985-90. PubMed ID: 9604881
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand.
Dhe-Paganon S; Duda K; Iwamoto M; Chi YI; Shoelson SE
J Biol Chem; 2002 Oct; 277(41):37973-6. PubMed ID: 12193589
[TBL] [Abstract][Full Text] [Related]
5. Identification of critical residues for heterodimerization within the ligand-binding domain of retinoid X receptor.
Lee SK; Na SY; Kim HJ; Soh J; Choi HS; Lee JW
Mol Endocrinol; 1998 Mar; 12(3):325-32. PubMed ID: 9514150
[TBL] [Abstract][Full Text] [Related]
6. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
7. Dimerization defective MODY mutations of hepatocyte nuclear factor 4α.
Singh P; Tung SP; Han EH; Lee IK; Chi YI
Mutat Res; 2019 Mar; 814():1-6. PubMed ID: 30648609
[TBL] [Abstract][Full Text] [Related]
8. Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alpha1: modulation by the F domain.
Ruse MD; Privalsky ML; Sladek FM
Mol Cell Biol; 2002 Mar; 22(6):1626-38. PubMed ID: 11865043
[TBL] [Abstract][Full Text] [Related]
9. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205.
Maeda Y; Rachez C; Hawel L; Byus CV; Freedman LP; Sladek FM
Mol Endocrinol; 2002 Jul; 16(7):1502-10. PubMed ID: 12089346
[TBL] [Abstract][Full Text] [Related]
10. Maturity-onset diabetes of the young Type 1 (MODY1)-associated mutations R154X and E276Q in hepatocyte nuclear factor 4alpha (HNF4alpha) gene impair recruitment of p300, a key transcriptional co-activator.
Eeckhoute J; Formstecher P; Laine B
Mol Endocrinol; 2001 Jul; 15(7):1200-10. PubMed ID: 11435618
[TBL] [Abstract][Full Text] [Related]
11. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.
Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI
Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992
[TBL] [Abstract][Full Text] [Related]
12. Critical role of residues defining the ligand binding pocket in hepatocyte nuclear factor-4alpha.
Aggelidou E; Iordanidou P; Tsantili P; Papadopoulos G; Hadzopoulou-Cladaras M
J Biol Chem; 2004 Jul; 279(29):30680-8. PubMed ID: 15123688
[TBL] [Abstract][Full Text] [Related]
13. Mutations in hepatocyte nuclear factor 4alpha (HNF4alpha) gene associated with diabetes result in greater loss of HNF4alpha function in pancreatic beta-cells than in nonpancreatic beta-cells and in reduced activation of the apolipoprotein CIII promoter in hepatic cells.
Oxombre B; Moerman E; Eeckhoute J; Formstecher P; Laine B
J Mol Med (Berl); 2002 Jul; 80(7):423-30. PubMed ID: 12110948
[TBL] [Abstract][Full Text] [Related]
14. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
Narayana N; Hua Q; Weiss MA
J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
[TBL] [Abstract][Full Text] [Related]
15. The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors.
Miyamoto T; Kakizawa T; Ichikawa K; Nishio S; Takeda T; Suzuki S; Kaneko A; Kumagai M; Mori J; Yamashita K; Sakuma T; Hashizume K
Mol Cell Endocrinol; 2001 Jul; 181(1-2):229-38. PubMed ID: 11476956
[TBL] [Abstract][Full Text] [Related]
16. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes.
Torres-Padilla ME; Sladek FM; Weiss MC
J Biol Chem; 2002 Nov; 277(47):44677-87. PubMed ID: 12205093
[TBL] [Abstract][Full Text] [Related]
17. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
18. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
20. Ligand specificity and conformational dependence of the hepatic nuclear factor-4alpha (HNF-4alpha ).
Petrescu AD; Hertz R; Bar-Tana J; Schroeder F; Kier AB
J Biol Chem; 2002 Jul; 277(27):23988-99. PubMed ID: 11940586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
